Archived Medical News Stories

RSSArchived Pharmaceutical News Stories - October 2004

Date Title Comments Rating
2004-10-29 U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season 0 None
2004-10-29 New data supporting the use of Renagel in patients who are new to hemodialysis 1 None
2004-10-29 Micro-array technology is revolutionising current drug development 0 None
2004-10-26 Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes 0 None
2004-10-26 Call for a Senate Inquiry into the pharmacy industry in Australia 0 None
2004-10-26 Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year 0 None
2004-10-25 New Drug Application for Velac accepted for filing by the FDA 0 None
2004-10-25 Arizona will receive 22,500 additional doses of flu vaccine 0 None
2004-10-25 Scientists are testing the effectiveness of a new type of flu vaccine 0 None
2004-10-25 Agreement reached on new community pharmacy contract 0 None
2004-10-25 The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK 0 None
2004-10-25 New oral vaccine treatment is effective in reducing Alzheimer's disease pathology 0 None
2004-10-25 Fatbuster drug targets obesity 0 None
2004-10-25 Call for disclosure of the prices of the most commonly-used prescription drugs over the Internet 0 None
2004-10-25 Following the withdrawal of Vioxx, the European Medicines Agency has been asked to review of COX-2 inhibitor medicines 0 None
2004-10-25 Infectious diseases physicians call for financial incentives for industry 0 None
2004-10-25 Rosiglitazone helps boost the effectiveness of a treatment for opening clogged arteries 0 None
2004-10-25 Boehringer Ingelheim - New Drug Application (NDA) for tipranavir 0 None
2004-10-22 MedImmune bumps up production of FluMist vaccine 0 None
2004-10-22 New advice on prescribing anti-depressants 0 None
2004-10-22 MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine 0 None
2004-10-21 New law will help stop litigation abuse against vaccines 0 None
2004-10-18 FDA grants traditional approval for Fuzeon (enfuvirtide), to treat HIV 0 None
2004-10-18 Campaign gives Florida residents 30,000 flu shots for free 1 None
2004-10-18 Chiron responds to FDA announcement 0 None
2004-10-18 Pfizer provides information about its COX-2 product Bextra (valdecoxib) 0 None
2004-10-16 FDA finds Chiron influenza vaccine unsafe for use 0 None
2004-10-13 Teva Pharmaceutical granted FDA approval for Flumazenil injection 0 None
2004-10-13 MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines 0 None
2004-10-13 California issues alert and warning about flu vaccine price gouging 0 None
2004-10-13 FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine 0 None
2004-10-12 CDC and Aventis Pasteur plan to allocate influenza vaccine 0 None
2004-10-11 New survey reveals continued drug price disparities across the New York State 0 None
2004-10-10 Pharmacists respond to unprecedented demand for the flu vaccine in the wake of the current shortage 0 None
2004-10-08 HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia 0 None
2004-10-08 Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines 0 None
2004-10-08 Aspirin might well be considered the top utility player in the medicine cabinet 0 None
2004-10-07 Vioxx: an unequal partnership between safety and efficacy 0 None
2004-10-07 Canadian Rheumatology Association issues statement on Vioxx alternatives 0 None
2004-10-06 EMEA statement following withdrawal of Vioxx (rofecoxib) 0 5
2004-10-05 Ireland's Department of Health has resolved outstanding concerns over the availability of flu vaccines 0 None
2004-10-05 U.S. healthcare industry reaction to the withdrawal of Vioxx from the world-wide market 0 None
2004-10-05 U.S. Department of Health and Human Services responds to loss of Chiron flu vaccine 0 None
2004-10-05 RiboNovix secures license to novel anti-infective discovery technology from Wayne State University 0 None
2004-10-05 Natural alternatives to osteoarthritis drug 0 None
2004-10-05 Teva Pharmaceuticals granted final approval for Ribavirin capsules 0 None
2004-10-05 A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease 0 None
2004-10-05 Analysis shows Teriparatide reduces fracture risk independent of bone turnover 0 None
2004-10-04 Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib) 0 None
2004-10-04 FDA fast tracks Genaera's drug for the treatment of wet age-related macular degeneration 0 None
2004-10-04 First U.S. program to allow citizens to purchase lower cost, safe prescription drugs from Europe and Canada 0 None
2004-10-04 Bristol-Myers Squibb submits New Drug Application to the U.S. Food and Drug Administration for entecavir 0 None
2004-10-04 MHRA advice following withdrawal of Vioxx (rofecoxib) 0 None
2004-10-04 Chiron grants a non-exclusive license to the German Red Cross 0 None
2004-10-04 Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain 0 None
2004-10-04 Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania 0 None


56 posts
1 raters